Palliative Surgery — Surgical Relief of Cancer Symptoms

Palliative surgery encompasses a broad array of operative interventions performed in patients with locally advanced or metastatic malignancies where curative resection is unachievable. The overriding surgical intent is to manage mechanical disruptions, severe pain, perforation, or uncontrolled haemorrhage caused by progressive tumour burden.

Procedures vary widely in complexity, from minimally invasive interventions—such as stenting or laparoscopy—to more extensive operations like diverting stomas, surgical bypasses, or debulking resections. Surgical teams carefully evaluate the balance between operative risks and expected symptomatic benefit, tailoring each approach to ensure minimal post-operative recovery time and maximal symptomatic relief.

Mechanical complications from cancer can cause unmanageable distress and rapidly undermine independence. Palliative surgery can resolve acute crises, such as a bowel obstruction that prevents eating, allowing a patient to return home in comfort. By alleviating severe local symptoms, successful palliative operations often enable individuals to regain sufficient physical resilience to continue palliative systemic therapies, spend meaningful time with loved ones, and maintain functional dignity.

The need for palliative surgery is evaluated through diagnostic imaging such as contrast-enhanced CT scans, MRI, or abdominal ultrasound to locate the source of obstruction or haemorrhage. Endoscopy allows direct visualisation of luminal blockages. While routine molecular biomarkers do not direct the decision to operate, baseline blood tests—including haemoglobin, renal function, and coagulation profiles—ensure surgical safety.

Palliative surgery is most frequently performed in advanced gastrointestinal cancers, such as colorectal, gastric, and pancreatic cancers. It is also common in gynaecological malignancies, notably advanced ovarian cancer causing bowel complications, as well as in breast, lung, and renal cell carcinomas metastasised to the skeleton, requiring orthopaedic stabilisation.

Palliative surgery is closely coordinated with medical and radiation oncology. Timing is critical, as active systemic chemotherapy or targeted therapies (such as anti-angiogenic agents) may need to be paused before and after surgery to minimise wound-healing complications. The procedure may also facilitate enteral feeding or relieve pain, indirectly supporting ongoing pharmacological palliative care.